Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What CAGR Is Anticipated for the Mid-Size Pharmaceuticals Market Through 2029?

There has been a noticeable surge in the market size of mid-size pharmaceuticals in recent times. The market which is projected to climb from $718.71 billion in 2024 to $760.71 billion in 2025, boasts a compound annual growth rate (CAGR) of 5.8%. Factors like growth of the generic drug market, expiration of patents for blockbuster drugs, measures to contain the cost of healthcare, the widening scope of biotechnology and regulatory alterations promoting innovation are responsible for this impressive growth in the historical phase.

In the ensuing years, a robust expansion is anticipated in the mid-size pharmaceuticals market, growing to “$983.81 billion in 2029 with a 6.6% compound annual growth rate (CAGR).” This expected growth in the forecast period can be credited to the rising shift towards value-based healthcare models, streamlined regulatory pathways, enhanced health consciousness and patient empowerment, demand surge for generic and biosimilar drugs, and the advent of digital therapeutics. Some major trends anticipated during the forecast period encompass an amplified emphasis on patient-centric methodologies, the incorporation of artificial intelligence (AI), strategies for global market expansion, initiatives for environmental sustainability, telemedicine and remote patient monitoring.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12045&type=smp

What Market Forces Are Driving The Mid-Size Pharmaceuticals Sector In 2025 And Beyond?

The growth in the mid-size pharmaceuticals market is anticipated to be spurred by the rising occurrence of chronic or non-communicable diseases. These are long-term health issues that necessitate continuous care and treatment, thus leading to a surge in the demand for medicines. Mass spectrometry methods are employed for the detection, measurement, and examination of biomarkers and metabolites related to chronic diseases. The mid-size pharmaceuticals market is set to grow in tandem with the escalating prevalence of chronic diseases. For instance, the World Health Organization, a UN specialized agency based in Switzerland, reported in September 2023 that 41 million deaths or 74% of global deaths are attributed to non-communicable diseases or chronic diseases every year. Consequently, the increasing incidence of chronic diseases is fueling the expansion of the mid-size pharmaceuticals market.

The mid-size pharmaceuticals market covered in this report is segmented –

1) By Drug Development Type: In-House, Outsource

2) By Type: Prescription, Over The Counter

3) By Formulation: Tablets, Capsules, Injectables, Sprays, Other Formulations

4) By Application: Cardiovascular Diseases, Pain Management, Diabetes, Cancer, Other Conditions

Subsegments:

1) By In-House: Research And Development (R&D) Departments, Clinical Trials Management

2) By Outsource: Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs)

What Long-Term Trends Are Likely To Affect The Mid-Size Pharmaceuticals Market?

The advancement of technology is a notable trend that is making waves in the mid-size pharmaceuticals market. Primarily driven by major firms, technology helps maintain their industry positions. For example, Google Cloud – a set of cloud computing services provided by Google – in May 2023, launched AI-equipped tools to speed up drug discovery and precision medicine. Their tool, Target and Lead Identification Suite, enables companies to predict and understand protein structure which is essential in drug research. Also, their Multiomics Suite aids researchers in handling, storing, evaluating, and disseminating large amounts of genetic data.

Which Firms Are Considered Leaders In The Mid-Size Pharmaceuticals Market Space?

Major companies operating in the mid-size pharmaceuticals market include Baxter International Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Alexion Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Eisai Co. Ltd., Wuxi AppTec co. Ltd., Les Laboratoires Servier S.A., Hospira Inc., Perrigo Co Plc, Aurobindo Pharma Lmited., Cipla Limited, Hikma Pharmaceuticals, Endo International plc, Taisho Pharmaceutical Holdings Co. Ltd., BioMarin Pharmaceutical Inc., Mallinckrodt Plc, Exelixis Inc., Mylan Pharmaceuticals Inc., Neurocrine Biosciences Inc., Kyowa Kirin Co. Ltd., Emergent BioSolutions Inc.

https://www.thebusinessresearchcompany.com/report/mid-size-pharmaceuticals-global-market-report

What Role Do Regional Policies And Investments Play In Mid-Size Pharmaceuticals Market Expansion?

North America was the largest region in the mid-size pharmaceutical market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mid-size pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12045&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model